Page 1

PharmaCorp R August 20 , 2026 Saskatoon , Saskatchewan ■ PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results Second quarter 2026 revenue up 75.8 % compared to the second quarter of 2025 Second quarter 2026 gross profit increased 78.2 % compared to the second quarter of 2025 Second quarter same - store sales were up 3.8 % , and same - store prescription sales were up 5.2 % , both compared to the second quarter of 2025 PHARMACORP RX INC . ( " PharmaCorp " or the " Corporation " ) ( TSXV : PCRX ) a Canadian pharmacy services and consolidation platform , today reported its financial results for the three and six months ended June 30 , 2026 . " Our second quarter reflected continued organic growth , disciplined integration , and active execution of acquisitions , " said Alan Simpson , Executive Chair of PharmaCorp . " With the closing of nine pharmacy acquisitions in July , together with the completion of the pharmacy acquisition in Western Canada on August 17 , we are building momentum in our strategy to acquire , integrate and operate high - quality community pharmacies across Canada . " Second Quarter 2026 Financial Highlights ■ ■ Second quarter 2026 revenue of $ 7.7 million compared to $ 4.4 million in the second quarter of 2025 , representing an increase of 75.8 % . Second quarter 2026 gross profit of $ 3.1 million compared to $ 1.7 million in the second quarter of 2025 with margins of 40.3 % and 39.8 % respectively . " ■ Second quarter 2026 Adjusted EBITDA ( Pre - IFRS 16 , 4 - Wall basis ) , a Non - IFRS Financial Measure , of $ 1.7 million compared to $ 0.7 million in the second quarter of 2025 , representing an increase of 148.7 % . Revenues , gross profit and Adjusted EBITDA , which is a Non - IFRS Financial Measure , were higher year - over - year due to increases in prescription volumes and front - of - store sales , and owning more pharmacies ( six as at June 30 , 2026 ) in the second quarter of 2026 versus the prior - year period ( three as at June 30 , 2025 ) . Same - store sales , a Supplementary Financial Measure , increased 3.8 % year - over - year compared to the second quarter of 2025 , reflecting continued organic growth across PharmaCorp's pharmacy network . Same - store prescription sales , a Supplementary Financial Measure , increase of 5.2 % year - over- year compared to the second quarter of 2025 , demonstrating sustained patient engagement and activity across the network . 1